Celldex Therapeutics, Inc. Logo

Celldex Therapeutics, Inc.

Develops antibody-based immunotherapies for severe inflammatory and allergic diseases.

CLDX | US

Overview

Corporate Details

ISIN(s):
US15117B2025
LEI:
Country:
United States of America
Address:
53 FRONTAGE ROAD, 8827 HAMPTON

Description

Celldex Therapeutics is a clinical-stage biopharmaceutical company that develops antibody-based immunotherapies. The company's research focuses on the intersection of mast cell biology and immunology to treat severe inflammatory, allergic, and autoimmune diseases. Its lead program is barzolvolimab, a humanized monoclonal antibody that inhibits KIT, a receptor tyrosine kinase essential for the function and survival of mast cells. By targeting this core pathological driver, Celldex aims to provide a best-in-class treatment option. The company leverages proprietary antibody programs and technologies supported by in-house discovery and development capabilities to advance its pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-06-17 22:12 English 7.3 KB
2024-06-17 22:11 English 7.2 KB
2024-06-17 22:10 English 7.2 KB
2024-06-17 22:10 English 7.3 KB
2024-06-17 22:08 English 7.2 KB
2024-06-17 22:04 English 7.2 KB
2024-06-17 22:03 English 7.3 KB
2024-06-17 22:03 English 7.2 KB
2024-06-17 22:02 English 7.3 KB
2024-06-14 23:34 English 7.3 KB
2024-06-14 23:12 English 7.4 KB
2024-06-14 22:02
FORM S-8
English 56.3 KB
2024-06-14 14:00
FORM 8-K
English 92.3 KB
2024-06-13 22:05 English 7.3 KB
2024-06-11 22:02 English 8.1 KB

Automate Your Workflow. Get a real-time feed of all Celldex Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celldex Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celldex Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.